With advances in surgical and anesthesia techniques, peri-operative mortality has markedly decreased. Presently cardiac complications are the most common cause of death. Clinical criteria and complexity of planned surgery predict the risk for adverse cardiac events. Only select patients require further evaluation such as stress testing for risk stratification. Coronary revascularization prior to surgery has not been shown to reduce the risk of cardiac events. Beta adrenergic blockers are beneficial when used with proper precautions. Management of anti-platelet and anticoagulant therapies during the peri-operative period will be described.

We will discuss the diagnosis and management of enlarged prostate, and when to order a prostate-specific antigen test. The speaker will elaborate on the diagnosis and management of enlarged prostate. Learners will walk away with improved confidence in knowing when to order a prostate-specific antigen test.

The speaker will review of latest recommendations for screening for osteoporosis, assessment of fracture risk, diagnosis of osteoporosis, treatment for fracture prevention, choice of pharmacologic agent, duration of treatment, and when to refer for specialist consultation.

Beginning with a case presentation, the session will consider classification and diagnosis of headaches, with emphasis on breakthrough findings about migraine aura that clarified the pathophysiology of migraine and radically changed treatment.

This talk will feature helpful information on allergic rhinitis and rhinosinusitis for primary care healthcare providers. In addition ,the faculty will provide updates on new research in both of these fields.

In this session, attendees will learn how to use a risk-based approach to the evaluation of patients with suspected PE or DVT. Attendees will learn strategies for risk stratification to identify patients with PE or DVT who are at increased risk for early and late complications and who may benefit from some of the advanced techniques now available. The role of anticoagulation for prevention of early recurrence as well as long-term extended prophylaxis will be emphasized.

Dementia afflicts over five million Americans. Although no cure exists, symptomatic treatments can provide temporary benefits and improve quality of life. Several medications that are effective in reducing symptoms and slowing decline are available, and other medicines and innovative treatments are in development. Healthy lifestyle habits have been shown to reduce risk and delay onset of symptoms. This presentation will review the latest information on diagnosis and treatment of dementia and discuss new approaches in the pipeline. The speaker will also highlight healthy behaviors shown to reduce symptoms, compensate for age-related cognitive decline, and protect brain health. * What's New in Dementia? may meet the criteria of the Medical Board of California for 0.75 credit of Geriatrics. Visit www.mbc.ca.gov for details.

The talk will cover inflammatory, neoplastic, and infectious diseases of the face, including periorbital, perioral, and malar geographies. Participants will learn to identify lesions in the context of differential diagnosis and receive an overview of first-line therapeutic approaches. Where applicable, newly approved medications in dermatology will be reviewed (e.g., psoriasis, eczema, and rosacea). Some disease states to be covered include acne, rosacea, allergic contact dermatitis, dermatomyositis, melanoma, basal cell carcinoma, melasma, and sarcoidosis.

Thyroid disorder is a common disorder and it effects all ages. In children, hypothyroidism can delay growth and mental development. In the elderly, thyroid disorders can result in severe hypothyroidism and death due to myxedema coma. All aspects of thyroid disease effects many medical providers. This talk will cover the most common and the most serious conditions that can be caused by abnormalities in thyroid function.

This lecture will address management of cigarette-smoking-related lung diseases, chronic bronchitis, and emphysema, and feature prevention (smoking abstinence and smoking cessation) and interventions (pharmacologic and nonpharmacologic). COPD is now the third most common cause of death in the United States. To improve care for their patients with COPD, participants will learn about diagnosing COPD, assessing its severity, and adjusting therapy according to that assessment. The speaker will also touch upon management of acute exacerbations of COPD in the ambulatory setting.

The speaker will illustrate how ADHD manifests in adulthood and explore assessment and management tools. In addition to a deep dive into the complicated interface between stimulant treatment and addiction, participants will learn about old and new stimulants along with behavioral interventions. Understanding mindfulness as a tool for ADHD will help learners make a difference in their patients with ADHD.